Mapping of low molecular weight heparins using reversed phase ion pair liquid chromatography-mass spectrometry.
暂无分享,去创建一个
Lianli Chi | Lequan Chi | Lan Jin | Xiaohui Xu | Daoyuan Li | Lequan Chi | Xuzhao Du | L. Chi | Lan Jin | Shengli Ji | X. Xu | Daoyuan Li | Xuzhao Du | S. Ji | Lianli Chi
[1] Jingwu Kang,et al. Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time of flight mass spectrometry and capillary zone electrophoresis. , 2013, Analytical chemistry.
[2] R. Linhardt,et al. The proteoglycan bikunin has a defined sequence , 2011, Nature chemical biology.
[3] Peter Roepstorff,et al. Ion-pairing reversed-phased chromatography/mass spectrometry of heparin. , 2006, Carbohydrate research.
[4] J. Harenberg. Overview on guidelines and recommendations for generic low-molecular-weight heparins. , 2011, Thrombosis research.
[5] Gary Benson,et al. GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data , 2012, PloS one.
[6] C. Larive,et al. Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins. , 2013, Journal of chromatography. A.
[7] R. Linhardt,et al. Mapping and quantification of the major oligosaccharide components of heparin. , 1988, The Biochemical journal.
[8] Robert Langer,et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events , 2008, Nature Biotechnology.
[9] Z. Shriver,et al. Sequencing complex polysaccharides. , 1999, Science.
[10] Weibin Chen,et al. Analysis of oligosaccharides derived from heparin by ion-pair reversed-phase chromatography/mass spectrometry. , 2009, Analytical chemistry.
[11] P. Mourier,et al. Chromatographic analysis and sequencing approach of heparin oligosaccharides using cetyltrimethylammonium dynamically coated stationary phases. , 2004, Analytical biochemistry.
[12] G. Jacobson,et al. Effective reversed-phase ion pair high-performance liquid chromatography method for the separation and characterization of intact low-molecular-weight heparins. , 2009, Analytical biochemistry.
[13] R. Linhardt,et al. Synthetic heparin. , 2012, Current opinion in pharmacology.
[14] E. Hilder,et al. A simple capillary electrophoresis method for the rapid separation and determination of intact low molecular weight and unfractionated heparins. , 2008, Journal of pharmaceutical and biomedical analysis.
[15] Robert J Linhardt,et al. Liquid Chromatography/Mass Spectrometry Sequencing Approach for Highly Sulfated Heparin-derived Oligosaccharides* , 2004, Journal of Biological Chemistry.
[16] R. Linhardt,et al. On-line separation and characterization of hyaluronan oligosaccharides derived from radical depolymerization. , 2013, Carbohydrate Polymers.
[17] R. Linhardt,et al. Photochemical Preparation of a Novel Low Molecular Weight Heparin. , 2012, Carbohydrate polymers.
[18] J. Weitz. Low-molecular-weight heparins. , 1997, The New England journal of medicine.
[19] Andre Raw,et al. Scientific considerations in the review and approval of generic enoxaparin in the United States , 2013, Nature Biotechnology.
[20] R. Linhardt,et al. Electrophoresis for the analysis of heparin purity and quality , 2012, Electrophoresis.
[21] J. Xie,et al. Structural analysis of bikunin glycosaminoglycan. , 2008, Journal of the American Chemical Society.
[22] B. Cosmi,et al. Old and new heparins. , 2012, Thrombosis research.
[23] Robert J Linhardt,et al. Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS. , 2012, Analytical Chemistry.